|  | sRAGE# | esRAGE# | ||
---|---|---|---|---|---|
Characteristics | univariate (R) | multivariate (β) | univariate (R) | multivariate (β) | |
Age (years) | 59 ± 7 | 0.22* | - | 0.23* | 0.24** |
Gender (f/m) | 24/86 | - | 0.21* | - | - |
Diabetes duration (years) | 13 ± 8 | 0.11 | - | 0.11 | - |
BMI (kg/m2) | 33 ± 6 | 0.04 | - | -0.04 | - |
HbA1c (%) | 7.4 ± 1.2 | -0.02 | - | 0.05 | - |
Fasting glucose (mmol/l) | 8.2 ± 3.0 | 0.05 | - | 0.05 | - |
Glomerular filtration rate (ml/min) | 128 ± 50 | -0.15 | - | -0.14 | - |
mean 24 h systolic BP (mmHg) | 141 ± 16 | 0.02 | - | -0.06 | - |
mean 24 h diastolic BP (mmHg) | 80 ± 8 | -0.14 | - | -1.8 | - |
24 h Albumin excretion (mg)# | 170 ± 406 | 0.18* | 0.22* | 0.10 | - |
Macrovascular Complications (%) | 33 | Â | Â | Â | Â |
Retinopathy (%) | 27 | Â | Â | Â | Â |
Polyneuropathy (%) | 52 | Â | Â | Â | Â |
Insulin therapy (%) | 64 | Â | Â | Â | Â |
ACE-Inhibitors/AT-R antagonists (%) | 88 | Â | Â | Â | Â |